---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-023676"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2025-07-28T23:59:59+00:00"
generated_at: "2026-05-18T00:37:21.980229+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NRC Health Q2 2025: TRCV grows 2% sequentially; net margin 0% on exec comp; adj EBITDA margin 30%

## Summary
- TRCV grew 2% sequentially, third consecutive quarter of growth and highest since Q1 2021.
- Net margin 0% due to non-recurring executive compensation; adjusted EBITDA margin 30%.
- Declared $0.12 quarterly dividend; payable Oct 10, 2025 to holders of record Sept 26, 2025.
- Repurchased 381,736 shares at $14.96 avg in Q2; $16.1M returned to shareholders YTD.
- New CEO Trent Green reinstated quarterly earnings call; cites strong customer feedback.

## SEC filing metadata
- accession: 0001437749-25-023676
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2025-07-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774925023676/0001437749-25-023676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774925023676/nrc20250725_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-023676
- JSON: https://secwatch.observer/filing/0001437749-25-023676.json
- Plain text: https://secwatch.observer/filing/0001437749-25-023676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.